Midlife Learning

Mood Changes

Clinically reviewed and approved by Effica's Health Strategy Team
Content last revised March 18, 2026

Key Facts

Mood symptoms are a common but often underrecognized part of the menopausal transition.

Between 40 and 50 percent of women report some degree of mood disturbance during perimenopause, including irritability, anxiety, tearfulness, and emotional variability.⁴ These symptoms can occur even in women without a prior psychiatric history.³

While mood changes do not always meet criteria for a clinical mood disorder such as major depression, they can still affect quality of life, relationships, and work performance.

Research suggests that women in perimenopause are at increased risk of developing new onset major depressive episodes compared with women who are premenopausal or postmenopausal.¹

Choose how you would like to learn

Here are the essentials—what every woman should know

Common and often overlooked

Between 40 and 50 percent of women report mood changes such as irritability, anxiety, or tearfulness during perimenopause, even without a prior history of depression.1,2,3,4,6

Increased risk of depression

Perimenopause is associated with a higher risk of new onset major depression compared with pre-menopause or postmenopause.3,4,6,8

Hormonal influence

Fluctuating estrogen levels during perimenopause affect brain chemicals such as serotonin, dopamine, and GABA that regulate mood.1,4,7 These shifts may increase emotional sensitivity and vulnerability to anxiety or low mood.

Sleep disruption affects mood

Up to 47 percent of perimenopausal and 60 percent of postmenopausal women report significant insomnia.4,10 Poor sleep, often linked with hot flashes, increases risk of depression and anxiety.

Midlife stress adds load

Caregiving responsibilities, work demands, relationship changes, and body image shifts can compound biologically driven mood changes.1,2,6,8

Personal history matters

Women with prior severe PMS, postpartum depression, or anxiety and depression are more likely to experience mood disturbance during the menopause transition. 1,3,6

Impact on daily life and health

Mood symptoms can reduce concentration, motivation, and confidence, strain relationships, affect work performance, and increase risk of major depression, anxiety disorders, substance misuse, and poorer physical health outcomes. 1,2,6,8

Lifestyle strategies are first line

Regular exercise, structured sleep routines, and stress management approaches such as mindfulness or cognitive behavioral therapy can improve mood, sleep, and resilience. 6,8

Medical options are available

Hormone therapy may improve mood when vasomotor symptoms are present. Antidepressants such as SSRIs or SNRIs are effective for mood symptoms and may reduce hot flashes. 5-8 Gabapentin or clonidine may be considered when sleep disruption is the primary concern.

Seek support early

Professional evaluation is recommended if mood symptoms last longer than two weeks, significantly impair daily life, or include hopelessness, loss of interest, panic, or thoughts of self harm. 6,8

Continue your journey—discover more insights and guidance.

Back To Midlife Learning

Here's what to know—clear context and practical detail

Symptoms

Mood changes are common during the menopausal transition. 

Up to half of women report irritability, anxiety, tearfulness, or emotional variability during perimenopause.1,4 These changes can occur even in women with no prior history of depression.

For some women, symptoms are mild. For others, they affect work, relationships, sleep, and confidence.

Perimenopause is also associated with an increased risk of new onset major depression compared with premenopause or postmenopause.3

If your mood feels different in your forties or fifties, it is reasonable to ask whether hormones may be playing a role.

Mood symptoms during perimenopause and menopause usually reflect the interaction of biology, sleep, and life stressors.

  • Fluctuating Estrogen Levels- During perimenopause, estrogen levels fluctuate unpredictably before eventually declining. Estrogen influences brain systems involved in mood regulation, including serotonin, dopamine, and gamma aminobutyric acid.7 When estrogen levels shift, some women become more sensitive to anxiety or low mood. These changes are biologically influenced. They are not a sign of weakness.
  • Sleep Disruption- Sleep disturbance is very common during this stage. Up to 47 percent of perimenopausal women and 35 to 60 percent of postmenopausal women report significant insomnia.10 Hot flashes and night sweats often interrupt sleep, but sleep problems can also occur independently. Poor sleep reduces emotional resilience and increases vulnerability to anxiety and depression.10 Improving sleep can meaningfully improve mood.
  • Midlife Stressors- Midlife often includes significant responsibilities and transitions. These may include caregiving, career changes, relationship shifts, or changes in body image and sexual health.9

Women with a history of severe premenstrual symptoms, postpartum depression, or prior anxiety or depression are at higher risk of mood disturbance during perimenopause.1 Understanding this broader context helps connect symptoms to the bigger picture.

Impact
Mood changes can influence:

  • Motivation
  • Concentration
  • Patience
  • Confidence
  • Communication in relationships
  • Work performance

Persistent mood symptoms are associated with increased risk of developing a major depressive disorder, anxiety disorders, and substance misuse.56
Sleep disruption, which often occurs alongside mood symptoms, is also linked with reduced quality of life and increased cardiovascular risk.10
Early recognition allows for earlier support.

Management
Most women benefit from a combination of strategies.

Lifestyle Foundations

  • Regular aerobic and resistance exercise improves mood and sleep quality and may reduce vasomotor symptoms.10
  • Prioritizing sleep hygiene is essential. This includes a consistent sleep schedule, limiting caffeine and alcohol before bed, and maintaining a cool, dark bedroom environment.10
  • Cognitive behavioral therapy can also be effective for depressive symptoms, anxiety, and insomnia.6

Medical Options

  • For moderate to severe or persistent symptoms, medical treatment may be appropriate.
  • Hormone therapy may improve mood in symptomatic perimenopause, particularly when hot flashes and sleep disruption are present.5 It should be considered based on timing, medical history, and individual risk factors.8
  • Antidepressants, including SSRIs and SNRIs, are effective for depression and anxiety and may also reduce vasomotor symptoms for some women.
  • Other medications such as gabapentin may be considered when sleep disruption is the primary concern.

Treatment decisions should be collaborative and individualized.

When to Seek Help

Professional evaluation is recommended if mood symptoms: 

  • Last more than two weeks 
  • Significantly interfere with daily functioning or relationships 
  • Include hopelessness or loss of interest 
  • Involve panic attacks 
  • Include thoughts of self-harm 

Women with a history of perinatal or premenstrual mood disorders may benefit from early evaluation during perimenopause. 

Mood symptoms are treatable. Support can make a meaningful difference. 

At Effica Health, we provide clinician led virtual care for women navigating perimenopause and menopause. We connect symptoms, hormones, sleep, mood, and health history into one clear picture. Our approach is evidence informed, collaborative, and judgment free. We help you understand what may be driving your symptoms and explore options that align with your health goals. 

Midlife care, made for you. 

Summary

Mood symptoms are a common component of the menopausal transition. They reflect the interaction of fluctuating estrogen levels, sleep disturbance, and midlife stressors.

Symptoms may range from mild irritability to major depressive episodes. They are treatable and should not be dismissed.

Early recognition allows for thoughtful intervention using lifestyle strategies, psychological therapies, and medical treatment when appropriate.

With clinician led, evidence informed support, most women can navigate this transition with greater stability, clarity, and confidence.

Here's the full picture

Mood symptoms during perimenopause and menopause reflect the interaction of biological, psychological, and social factors. 

From a biological perspective, fluctuating and eventually declining estrogen and progesterone levels play a central role. Estrogen influences neurotransmitters in the brain, including serotonin, dopamine, and gamma aminobutyric acid, which are involved in mood regulation.⁷ 

During perimenopause, hormone levels can fluctuate unpredictably. These shifts may increase emotional sensitivity and vulnerability to anxiety or depression. 

Sleep disturbance is another major contributor. Between 35 and 60 percent of postmenopausal women and up to 47 percent of perimenopausal women report significant sleep difficulties, particularly insomnia.10 Sleep disruption is often linked to hot flashes and night sweats, though it can occur independently. Poor sleep reduces emotional resilience and may intensify symptoms of anxiety and depression.

Midlife also includes complex social and personal transitions. Women may be balancing caregiving responsibilities, career demands, changes in body image, or shifts in sexual health.5 These stressors can interact with biological changes to influence mood.

Women with a history of severe premenstrual symptoms, postpartum depression, or prior episodes of anxiety or depression are at increased risk of mood disturbance during this transition.4

Impact

Mood symptoms during menopause can influence many aspects of daily life.

Women may experience reduced motivation, fatigue, difficulty concentrating, or changes in confidence. Emotional variability can affect communication and strain relationships. In the workplace, irritability or reduced focus may affect performance and satisfaction.

Persistent mood symptoms are associated with increased risk of major depressive disorder, generalized anxiety disorder, and substance misuse.6 Sleep disorders, which often co occur, are linked with increased cardiovascular risk and reduced quality of life.10

Mood changes can also affect engagement in health promoting behaviors such as exercise, balanced nutrition, and preventive care.2 Early recognition and support are important for both emotional and physical health.

Several factors increase vulnerability to mood symptoms during perimenopause.

These include:

  • Personal or family history of depression or anxiety
  • History of severe premenstrual syndrome or postpartum mood disorders
  • Ongoing sleep disturbance
  • Frequent vasomotor symptoms
  • Significant life stressors such as caregiving burden, relationship strain, or financial pressure

Certain behaviors can worsen symptoms. Chronic sleep deprivation, high stress, and alcohol use may intensify emotional instability.

Protective factors include regular physical activity, consistent sleep routines, balanced nutrition, and strong social support. Stress reduction practices such as mindfulness and relaxation techniques may also support emotional stability. For some women, hormone therapy or antidepressant medications are appropriate components of care.

Management is most effective when it is individualized and multifaceted.

Lifestyle Foundations

  • Lifestyle strategies are often first line. Regular aerobic and resistance exercise has been shown to improve mood and sleep quality. Exercise may also reduce vasomotor symptoms.
  • Prioritizing sleep hygiene is essential. This includes maintaining a consistent sleep schedule, limiting caffeine and alcohol before bed, and creating a cool, dark sleep environment.10
  • Stress management strategies such as mindfulness, cognitive behavioral therapy, and relaxation practices have demonstrated benefit for anxiety and depressive symptoms.6

Complementary Approaches

  • Some women explore complementary therapies such as acupuncture, yoga, or omega 3 supplements. Evidence is mixed but suggests possible benefit for some individuals.
  • Herbal products such as black cohosh or St John’s Wort require caution due to variability in preparation and potential medication interactions. Discussion with a clinician is recommended before starting supplements.

Medical Treatment Options

Medical treatment may be appropriate for moderate to severe or persistent symptoms.

  • Menopausal hormone therapy may improve mood in symptomatic perimenopause, particularly when vasomotor symptoms and sleep disturbance are present.6 It should be considered based on individual health history and risk profile.8
  • Antidepressants, including SSRIs and SNRIs, are effective treatments for depression and anxiety and may also reduce vasomotor symptoms for some women.
  • Other medications such as gabapentin may be considered when sleep disruption is a primary concern.

Treatment decisions should be collaborative and based on clinical history, symptom severity, and patient preference.

When to Seek Help

Professional evaluation is recommended if mood symptoms:

  • Persist for more than two weeks
  • Significantly impair daily functioning or relationships 
  • Include hopelessness or loss of interest 
  • Involve panic attacks 
  • Include thoughts of self harm 

Women with a history of perinatal or premenstrual mood disorders should consider early evaluation during perimenopause. 

Timely assessment and support improve outcomes. 

Self care plays an important role in supporting emotional stability. 

Helpful practices include: 

  • Regular physical activity 
  • Nutrient dense meals 
  • Consistent sleep and wake times 
  • Daily stress reduction practices such as journaling, yoga, or breathing exercises 
  • Maintaining social connection 
  • Scheduling enjoyable activities 

Tracking mood, sleep, and vasomotor symptoms can help identify patterns and guide clinical conversations. 

Small, consistent changes often contribute to meaningful improvement over time. 

Summary

Mood symptoms are a common component of the menopausal transition. They reflect the interaction of fluctuating estrogen levels, sleep disturbance, and midlife stressors.

Symptoms may range from mild irritability to major depressive episodes. They are treatable and should not be dismissed.

Early recognition allows for thoughtful intervention using lifestyle strategies, psychological therapies, and medical treatment when appropriate.

With clinician led, evidence informed support, most women can navigate this transition with greater stability, clarity, and confidence.

If you’d like to read more, please check out other resources we trust:

Society of Obstetricians and Gynaecologists of Canada (SOGC) – Menopause Patient Resources

Canadian Mental Health Association (CMHA)

The Menopause Society (NAMS)

Sharing is caring

Know someone who could use this information? Pass it along.

Copy Link
Link copied!
  1. Bromberger, J. T., & Epperson, C. N. (2018). Depression during and after the perimenopause: Impact of hormones, genetics, and psychosocial factors. Biological Psychiatry, 83(6), 386–396.  
  2. Bromberger, J. T., & Kravitz, H. M. (2011). Mood and menopause: Findings from the Study of Women’s Health Across the Nation (SWAN) over ten years. Obstetrics and Gynecology Clinics of North America, 38(3), 609–625. 
  3. Cohen, L. S., Soares, C. N., Vitonis, A. F., Otto, M. W., & Harlow, B. L. (2006). Risk for new onset of depression during the menopausal transition: The Harvard Study of Moods and Cycles. Archives of General Psychiatry, 63(4), 385–390. 
  4. Freeman, E. W., Sammel, M. D., Lin, H., & Nelson, D. B. (2004). Associations of hormones and menopausal status with depressed mood in women with no history of depression. Archives of General Psychiatry, 61(1), 62–70. 
  5. Gordon, J. L., & Girdler, S. S. (2014). Hormone replacement therapy in the treatment of perimenopausal depression. Current Psychiatry Reports, 16(12), 517. 
  6. Maki, P. M., Kornstein, S. G., Joffe, H., et al. (2018). Guidelines for the evaluation and treatment of perimenopausal depression: Summary and recommendations. Menopause, 25(10), 1069–1085. 
  7. Schmidt, P. J., Ben Dor, R., Martinez, P. E., Guerrieri, G. M., Harsh, V. L., Thompson, K., & Rubinow, D. R. (2015). Effects of estradiol withdrawal on mood in women with past perimenopausal depression: A randomized clinical trial. JAMA Psychiatry, 72(7), 714–726.  
  8. Shea, A. K., Wolfman, W., Fortier, M., & Soares, C. N. (2021). Guideline No. 422c: Menopause: Mood, Sleep, and Cognition. Journal of Obstetrics and Gynaecology Canada, 43(9), 1316–1323.e1.  
  9. Soares, C. N. (2017). Mood disorders in midlife women: Understanding the critical window and its clinical implications. Menopause, 24(2), 132–134.  
  10. Tandon, V. R., Sharma, S., Mahajan, A., Mahajan, A., & Tandon, A. (2022). Menopause and Sleep Disorders. Journal of Mid-Life Health, 13(1), 26–33.  
  • Nese Yuksel, BSc Pharm, PharmD, FCSHP, MSCP
  • Lindsay Torok-Both, BSc Pharm, ACPR, MSCP
  • Christine Maslanko, BSc Pharm, ACPR, MSCP
  • Victoria Groves, BScN MN, NP, MSCP
  • Susan Poon, BScN, MN, NP
  • Monique Lavoie, BScPh, RPh, CDE, APA, CTHCailee Heggestad, RD
  • Dr. Nan Schuurmans, MD, FRCSC
  • Dr. Catherine Hansen, MD, MPH, FRCSC, FACOG, MSCP
  • Dyan Eybergen, BA, RN, GCert-PM
  • Kayla McKinley, RN, BScN, BSc
  • Nicole Horinek-Castro, RN, BScN
  • Sarah Palen, BScPhm
  • Lunda Mbesha, MHS, BScN RN
  • Ashley Chartier, BSc Pharm, APA
  • Kate Bolohan, RN(EC), NP
  • Lena Ashrf, PharmD (Candidate)

Your first step toward clarity and confidence

Take our free Clarity Quiz—it only takes a few minutes to complete and helps you understand your stage of midlife health. You’ll receive personalized insights and actionable next steps, delivered straight to your inbox.

Take Our Clarity Quiz

Ready for support that meets you where you are? Explore Effica’s care.

See Your Options
Scroll to Top